| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.57 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.33 | 0.08 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |